Advertisement

Topics

Companies Related to "Vestibular Evoked Myogenic Potential: A New Device Propose" [Most Relevant Company Matches] - Page: 5 RSS

06:48 EDT 24th March 2019 | BioPortfolio

Here are the most relevant search results for "Vestibular Evoked Myogenic Potential: A New Device Propose" found in our extensive corporate database of over 50,000 company records.

Showing "Vestibular Evoked Myogenic Potential Device Propose" Companies 101–125 of 2,900+

Probably Relevant

Algomedix Inc.

Algomedix Inc., a biotech company located in Mill Creek WA, and San Diego, CA, is developing potential first-in-class non-opioid medicines for chronic and acute pain. The company’s patented TRPA1 modulators, which are small molecule, orally delivered compounds, are designed to provide effective pain relief without any potential for addiction or abuse....


InPress Technologies

Located in Mountain View, Calif., InPress Technologies is committed to developing a medical device that will eradicate maternal death caused by postpartum hemorrhage (PPH). With its simple, non-invasive InPress device, the company aims to improve the lives of women around the world. More information on InPress Technologies is available at www.inpresstechnologies....

XenoPort

We are a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates for the potential treatment of central nervous system (CNS) disorders. We also have a product candidate for the potential treatment of gastroesophageal reflux disease, or GERD. Our drug discovery efforts focus on utilizing the body's natural nutrient transporter mechanisms to improve th...


SpineGuard

Co-invented by Maurice Bourlion, Ph.D., and Ciaran Bolger, M.D., Ph.D., PediGuard is the world’s first and only handheld device capable of alerting surgeons to potential pedicular or vertebral breaches. Real-time feedback is provided via audio and visual signals. Nearly 12,000 procedures have been performed with PediGuard on all continents. Two multi-...

Queensland Cancer Fund

The Queensland Cancer Fund was established in 1961 in response to a desperate need in the community. Cancer mortality was on the increase and available resources could not cope with the problem. A small group of concerned people decided to form the Queensland Cancer Fund and began planning a strategy for raising funds to combat the disease and provide adequate treatment facilities for cancer patie...

Horizon Pharma plc

Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their careg...

Algos Therapeutics, Inc

Algos Therapeutics is a privately held, independent research company specializing in the evaluation of potential pain treatments under development. The data we generate from our models have proven highly predictive for activity in human pain. And, the information derived is invaluable for the discovery of potential breakthrough treatments for pain. This is a vital component of our clients’ pain ...

Ventracor Limited

Ventracor is an international medical device company focused on commercialising the world’s leading ‘artificial heart’ device, the VentrAssist™ Left Ventricular Assist Device (LVAD). The VentrAssist™ is a new third generation implantable heart device primarily designed as an alternative to heart transplantation for people with cardiac failure. It may also be used for patients waiting for...

ev3

ev3 Inc. is a leading worldwide medical device company one hundred percent focused on catheter-based or endovascular technologies for the minimally invasive treatment of vascular disease and disorders. Our name signifies our commitment to serve the three endovascular markets – Peripheral Vascular, Cardiovascular and Neurovascular – and to be a global provider of products for underserved and em...

Quintiles Scotland

Safety PharmacologyQuintiles has safety pharmacology services to identify the potential adverse pharmacological effects of new chemical entities prior to first administration to man. Regulatory Safety Pharmacology packages Haemodynamics/ECG studies Cardiac action potential in vitro QT prolongationIon channels (e.g. HERG) Discovery SupportQuintiles pharmacologists can provide support in defining th...

IMDS Corporation

IMDS (Innovative Medical Device Solutions) is the strategic source for contract, full-service medical device development and manufacturing. With an intense focus on innovation, speed to market, and our partners' goals, we deliver products that enhance the quality of life and standard of care for patients. For more information about IMDS, please visit www.imds.net...

Acumen Pharmaceutical Services Limited

acumen is a privately owned Product Development Contract Research Company, specifically set-up to aid Pharmaceutical, Biotechnology and Device companies to investigate rapidly and determine the potential of new and existing products. Employing a consultative approach to clinical research we customise solutions based on the needs of our clients and ensure a fast, accurate and cost effective service...

FineHeart

FineHeart is a French medical device company founded by a team of internationally renowned cardiac surgeons and cardiologists together with experienced managers in the cardiovascular device industry. They adopted a vision of making a miniaturized, fully implantable, pulsatile circulatory support system that would overcome most of the challenges associated...

Texas Healthcare & Bioscience Institute

The Texas Healthcare & Bioscience Institute is composed of biotechnology, medical device, and pharmaceutical companies, universities and private research institutions, and companies that provide goods and services to core organizations. The goal of THBI is to develop solid information about the medical research and manufacturing community in Texas, and to make that information available to politic...

Two Pore Guys, Inc.

Two Pore Guys (2PG) develops single-molecule sensing technologies that employ solid-state nanopores and biochemical reagents to create a versatile sample-in/results-out detection platform. 2PG’s first product is a handheld device that can use reagents from existing molecular or analyte diagnostic assays and provide accuracy and sensitivity rivaling so...

Virtual Incision Corporation

Virtual Incision Corporation is a privately held medical device company based in Lincoln, Neb. and Pleasanton, Calif. The company’s first-of-its-kind miniaturized robotically assisted surgical devices for general surgery are designed to enable a minimally invasive approach to a variety of procedures that are typically performed 'open’ today, with ...

Symmetry Medical

Symmetry Medical (NYSE:SMA) is a leading provider of implants, instruments and cases to orthopedic device manufacturers. We also design, develop and produce these products for companies in the arthroscopy, dental, laparoscopy, osteobiologic, endoscopy and other segments of the medical device market, as well as provide specialized products and services to the aerospace market.

Theorem Clinical Research Inc.

Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world's leading pharmaceutical, biotech and medical device companies. A world leader in the most complex medical device and drug-device combinati...

Genkyotex

Genkyotex is developing first in class, small molecule therapeutics that specifically and selectively inhibit the NOX family of enzymes. Using a unique screening platform, Genkyotex has identified novel NOX inhibitors with the potential to treat disease areas with a high clinical need and large market potential. Genkyotex was founded in 2006 by scientists ...

Starkey Hearing Technologies

The Xino™ Tinnitus device, sold under the Starkey brand, uses advanced technology to create a customizable and comforting sound stimulus that can be fine-tuned and personalized for a person’s individual sound therapy needs. The nearly invisible device, worn behind the ear, delivers a innovative technology that personalizes treatment to address ea...

PaceMate™

PaceMate™ was founded in 2015 by cardiac rhythm management industry professionals who experienced firsthand the overwhelming amount of device data inundating clinicians on a daily basis. The PaceMate™ team saw a need to develop innovative technology to streamline the device clinic, improve workflow, reduce medical errors, and take better care of ...

EmFinders(TM)

EmFinders, based in Frisco, TX, is a new technology company that has developed a device and subscription service for locating people with Alzheimer's or other impaired adults and children who wander and become lost. The wearable device and locator service uses advanced cellular technology to locate lost individuals, even if they wander inside a building, under a structure or just about anywhere. T...

Karus Therapeutics

Karus Therapeutics is a leader in the development of innovative medicines that have breakthrough potential in treating inflammatory disease and cancer. The Company’s scientific excellence is reflected in its proprietary PI3K and HDAC6 inhibitor programmes, from which innovative small molecule drugs with significant clinical and commercial potential ha...

WuXi PharmaTech (Cayman) Inc.

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed t...

Berlin Heart,Inc

In 1997 the acquisition of the paracoporeal device with the name"Berlin Heart" from the company Fehling Medical AG took place the Mediport Berlin Heart Gmbh Kardiotechnik Was Founded.In order to make VAD Patients Independent from hospitals and allow them to live their life with such a device at home,asmaller, mobile driving unit was developed in 1997.The CE approval and introduction to the market ...


More From BioPortfolio on "Vestibular Evoked Myogenic Potential: A New Device Propose"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks